IPCA Laboratories Current Share Price | IPCA Laboratories Stock Screener
IPCALAB
Pharmaceuticals
IPCA Laboratories Current Stock Price Today
Live Share Price NSE
₹2009.60
▲
39.30 (1.99%)
Live Share Price BSE
₹2011.00
▲
41.20 (2.09%)
As of September 18, 2026, the live IPCA Laboratories share price (NSE: IPCALAB) is ₹2,009.60 on NSE and ₹2,011.00 on BSE, up 1.99% from the previous close, with shares trading between ₹1,964.00 and ₹2,038.00 in today's trading session, and a 52-week range of ₹1,268.70–₹2,009.60.
Browse IPCALAB financial statements to support your investment research.
Use the IPCA Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
IPCA Laboratories Market Cap
₹49,941.68 Cr.
IPCALAB P/E Ratio (TTM)
36.35
IPCA Laboratories P/B Ratio
6.20
EPS (TTM)
₹44.98
Dividend Yield
0.30%
Debt to Equity
0.14
IPCALAB 52 Week High
₹2009.60
IPCA Laboratories 52 Week Low
₹1268.70
Operating Margin
18.00%
Profit Margin
12.37%
IPCALAB Revenue (TTM)
₹2,482.00
EBITDA
₹532.00
Net Income
₹307.00
Total Assets
₹12,370.00
Total Equity
₹9,524.00
IPCA Laboratories Current Share Price Chart
Track the current IPCA Laboratories share price and stock price with an interactive chart. Analyse IPCALAB price trends, trading volume, historical performance, and volatility across different timeframes — the complete IPCA Laboratories stock quote in one place.
IPCA Laboratories Company Profile - Fundamental Screener
Screen IPCA Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for IPCALAB shares.
Ipca Laboratories Limited is an Indian integrated pharmaceutical company that manufactures and markets over 350 formulations and 80 active pharmaceutical ingredients (APIs) across various therapeutic segments. The company operates 18 manufacturing units in India and sells its products in over 100 countries worldwide. Ipca specializes in producing APIs such as...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Premchand Godha
ISIN
INE571A01038
Website
https://www.ipca.com
IPCA Laboratories Balance Sheet Screener
Screen IPCALAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 12,370 | 11,761 | 11,101 | 8,626 | 7,639 | 6,068 | 5,260 | 4,551 | 4,117 | 3,960 |
| Current Assets | 6,374 | 5,967 | 5,536 | 5,189 | 4,447 | 3,437 | 2,856 | 2,378 | 1,946 | 1,742 |
| Fixed Assets | 4,627 | 4,267 | 4,553 | 2,751 | 2,418 | 2,072 | 2,059 | 1,940 | 1,953 | 1,983 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 539 | 986 | 1,019 | 905 | 604 | 192 | 292 | 315 | 421 | 548 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 9,524 | 8,388 | 7,727 | 5,915 | 5,569 | 4,716 | 3,641 | 3,138 | 2,689 | 2,455 |
| Share Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves & Surplus | 8,038 | 6,923 | 6,307 | 5,817 | 5,467 | 4,676 | 3,590 | 3,097 | 2,663 | 2,430 |
IPCA Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen IPCA Laboratories income statement and profit fundamentals.
Analyze IPCALAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for IPCA Laboratories share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,482 | 2,813 | 2,273 | 2,342 | 2,584 | 2,430 | 2,052 | 2,113 | 2,381 | 2,266 | 1,548 | 1,630 | 2,073 | 2,144 | 1,304 |
| Expenses | 1,950 | 2,119 | 2,023 | 1,892 | 2,070 | 1,859 | 1,848 | 1,700 | 1,913 | 1,782 | 1,331 | 1,278 | 1,713 | 1,722 | 1,070 |
| EBITDA | 532 | 695 | 250 | 449 | 515 | 571 | 204 | 413 | 468 | 483 | 217 | 353 | 360 | 422 | 234 |
| Operating Profit % | 18.00% | 24.00% | 10.00% | 18.00% | 19.00% | 22.00% | 9.00% | 19.00% | 19.00% | 21.00% | 12.00% | 19.00% | 16.00% | 16.00% | 17.00% |
| Depreciation | 107 | 111 | 100 | 100 | 103 | 108 | 98 | 99 | 100 | 99 | 70 | 69 | 90 | 100 | 61 |
| Interest | 20 | 12 | 22 | 19 | 20 | 18 | 29 | 24 | 23 | 17 | 19 | 31 | 44 | 33 | 3 |
| Profit Before Tax | 405 | 572 | 128 | 331 | 392 | 446 | 77 | 290 | 345 | 368 | 129 | 252 | 225 | 289 | 170 |
| Tax | 98 | 148 | 64 | 98 | 111 | 82 | 75 | 91 | 99 | 92 | 51 | 88 | 89 | 68 | 38 |
| Net Profit | 307 | 424 | 64 | 233 | 281 | 364 | 1 | 199 | 246 | 276 | 78 | 164 | 137 | 221 | 132 |
| EPS | 13.31 | 15.84 | 2.67 | 9.19 | 11.14 | 12.86 | 2.35 | 7.58 | 9.05 | 9.78 | 3.02 | 6.42 | 5.72 | 7.09 | 5.13 |
IPCA Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen IPCALAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1,142 | 1,321 | 945 | 806 | 856 | 1,090 | 570 | 501 | 341 | 282 |
| Investing Activities | -247 | -870 | -1,215 | -725 | -851 | -521 | -509 | -165 | -135 | -149 |
| Financing Activities | -754 | -283 | -553 | 507 | 427 | -306 | -137 | -183 | -130 | -159 |
| Net Cash Flow | 142 | 169 | -823 | 588 | 432 | 264 | -76 | 153 | 75 | -26 |
IPCA Laboratories Shareholding Pattern Screener
See IPCA Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check IPCA Laboratories promoter holding and ownership changes for IPCALAB on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.72% | 44.72% | 44.72% | 44.72% | 44.72% | 44.72% | 44.72% | 46.30% |
| FII Holding | 10.73% | 10.63% | 10.63% | 10.43% | 10.67% | 10.76% | 11.07% | 10.83% |
| DII Holding | 37.37% | 37.45% | 37.32% | 36.77% | 36.20% | 36.06% | 35.68% | 34.23% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 5.76% | 5.79% | 5.88% | 6.55% | 6.82% | 6.81% | 6.88% | 6.93% |
| Other Holding | 1.42% | 1.41% | 1.44% | 1.53% | 1.59% | 1.65% | 1.65% | 1.71% |
| Shareholder Count | 82,060 | 82,184 | 77,673 | 82,870 | 85,582 | 88,306 | 90,189 | 82,975 |
IPCA Laboratories Share Dividend Screener - Share Yield Analysis
Check IPCA Laboratories dividend history with payout and yield data.
View IPCA Laboratories dividend details including ex-dates and amounts for IPCALAB stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹4.00 | 0.25% |
| 2024-March | ₹4.00 | 0.27% |
| 2023-March | ₹4.00 | 0.32% |
| 2022-March | ₹8.00 | 1.02% |
| 2021-March | ₹8.00 | 0.75% |
| 2020-March | ₹5.00 | 0.53% |
| 2019-March | ₹3.00 | 0.43% |
| 2018-March | ₹1.00 | 0.20% |
| 2017-March | ₹1.00 | 0.31% |
IPCA Laboratories Stock Index Membership
See which indices include IPCA Laboratories stock.
Check IPCALAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE 200 EQUAL WEIGHT
BSE INDEX BSE HC
BSE INDEX BSE200
BSE INDEX BSE500
BSE INDEX LMI250
BSE INDEX MID150
BSE INDEX MIDCAP
BSE INDEX MSL400
NIFTY 500
NIFTY HEALTHCARE
NIFTY LARGEMID250
NIFTY MIDCAP 150
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY PHARMA
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH
NIFTYM150MOMNTM50
IPCA Laboratories Market Events Screener - Corporate Actions
Get IPCA Laboratories corporate actions including splits, bonuses, and buybacks.
Check IPCA Laboratories stock events that may affect IPCALAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | -0.59% |
| 2026-08-13 | 2026-08-13 | Annual General Meeting | NA | -1.19% |
| 2026-08-07 | 2026-08-07 | Dividend | ₹ 6.00 /share | 10.24% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 2.71% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | -0.54% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 4.12% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -5.30% |
| 2025-08-11 | 2025-08-11 | Annual General Meeting | NA | -4.14% |
| 2025-08-05 | 2025-08-05 | Dividend | ₹ 2.00 /share | -3.58% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 6.52% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -6.28% |
| 2024-11-27 | 2024-11-27 | Dividend | ₹ 2.00 /share | 3.99% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -3.83% |
| 2024-08-13 | 2024-08-13 | Annual General Meeting | NA | 13.43% |
| 2024-08-06 | 2024-08-07 | Dividend | ₹ 2.00 /share | 0.12% |
IPCA Laboratories Competitors Screener - Peer Comparison
Screen IPCALAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
IPCA Laboratories Company Announcements - News Screener
Screen IPCALAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-14 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-13 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-13 | Standalone And Consolidated Unaudited Financial Results For Q1FY27 | - |
| 2026-08-13 | Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results For Q1FY27 | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-28 | Board Meeting Intimation for Standalone And Consolidated Financial Results For 1St Quarter Ended 30Th June 2026 | - |
| 2026-07-17 | Intimation Of Web Link To Non-Email Cases | - |
| 2026-07-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-14 | Record Date For Dividend | - |
| 2026-07-14 | 76Th Annual General Meeting Of Ipca Laboratories Limited To Be Held On Thursday 13Th August 2026 | - |
| 2026-07-14 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-07-14 | Reg. 34 (1) Annual Report. | - |
| 2026-07-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-07 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-07-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-26 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | - |
| 2026-06-26 | Board Meeting Outcome for Outcome Of Board Meeting | - |